These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 39024172)
1. Li-Fraumeni Syndrome: Imaging Features and Guidelines. Gosangi B; Dixe de Oliveira Santo I; Keraliya A; Wang Y; Irugu D; Thomas R; Khandelwal A; Rubinowitz AN; Bader AS Radiographics; 2024 Aug; 44(8):e230202. PubMed ID: 39024172 [TBL] [Abstract][Full Text] [Related]
2. Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1. Kumamoto T; Yamazaki F; Nakano Y; Tamura C; Tashiro S; Hattori H; Nakagawara A; Tsunematsu Y Int J Clin Oncol; 2021 Dec; 26(12):2161-2178. PubMed ID: 34633580 [TBL] [Abstract][Full Text] [Related]
3. Li-Fraumeni Syndrome and Whole-Body MRI Screening: Screening Guidelines, Imaging Features, and Impact on Patient Management. Consul N; Amini B; Ibarra-Rovira JJ; Blair KJ; Moseley TW; Taher A; Shah KB; Elsayes KM AJR Am J Roentgenol; 2021 Jan; 216(1):252-263. PubMed ID: 33151095 [TBL] [Abstract][Full Text] [Related]
4. Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol. Dixon-Zegeye M; Shaw R; Collins L; Perez-Smith K; Ooms A; Qiao M; Pantziarka P; Izatt L; Tischkowitz M; Harrison RE; George A; Woodward ER; Lord S; Hawkes L; Evans DG; Franklin J; Hanson H; Blagden SP Trials; 2024 Feb; 25(1):103. PubMed ID: 38308321 [TBL] [Abstract][Full Text] [Related]
5. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Mai PL; Best AF; Peters JA; DeCastro RM; Khincha PP; Loud JT; Bremer RC; Rosenberg PS; Savage SA Cancer; 2016 Dec; 122(23):3673-3681. PubMed ID: 27496084 [TBL] [Abstract][Full Text] [Related]
8. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432 [TBL] [Abstract][Full Text] [Related]
9. Whole-body magnetic resonance imaging of Li-Fraumeni syndrome patients: observations from a two rounds screening of Brazilian patients. Paixão D; Guimarães MD; de Andrade KC; Nóbrega AF; Chojniak R; Achatz MI Cancer Imaging; 2018 Aug; 18(1):27. PubMed ID: 30107858 [TBL] [Abstract][Full Text] [Related]
10. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic. Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289 [TBL] [Abstract][Full Text] [Related]
11. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes. Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481 [TBL] [Abstract][Full Text] [Related]
12. A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancer. Cho Y; Kim J; Kim Y; Jeong J; Lee KA Ann Lab Med; 2013 May; 33(3):212-6. PubMed ID: 23667851 [TBL] [Abstract][Full Text] [Related]
13. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745 [TBL] [Abstract][Full Text] [Related]
14. Li-Fraumeni syndrome in Tunisian carriers with different and rare tumor phenotype: genotype-phenotype correlation. Sassi H; Meddeb R; Cherif MA; Nasr C; Riahi A; Hannachi S; Belguith N; M'rad R BMC Med Genomics; 2022 Mar; 15(1):44. PubMed ID: 35246108 [TBL] [Abstract][Full Text] [Related]
15. Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome. Le AN; Harton J; Desai H; Powers J; Zelley K; Bradbury AR; Nathanson KL; Shah PD; Doucette A; Freedman GM; Gabriel P; Domchek SM; MacFarland SP; Maxwell KN Breast Cancer Res Treat; 2020 May; 181(1):181-188. PubMed ID: 32246378 [TBL] [Abstract][Full Text] [Related]
16. Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes. Frebourg T; Bajalica Lagercrantz S; Oliveira C; Magenheim R; Evans DG; Eur J Hum Genet; 2020 Oct; 28(10):1379-1386. PubMed ID: 32457520 [TBL] [Abstract][Full Text] [Related]
17. [A rhabdomyosarcoma patient from a Li-Fraumeni syndrome family: a case report and literature review]. Xie Y; Zhao WH; Hua Y; Sun Q; Wu PH Zhongguo Dang Dai Er Ke Za Zhi; 2017 Dec; 19(12):1263-1266. PubMed ID: 29237527 [TBL] [Abstract][Full Text] [Related]
18. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome. Ribi S; Baumhoer D; Lee K; Edison ; Teo AS; Madan B; Zhang K; Kohlmann WK; Yao F; Lee WH; Hoi Q; Cai S; Woo XY; Tan P; Jundt G; Smida J; Nathrath M; Sung WK; Schiffman JD; Virshup DM; Hillmer AM Oncotarget; 2015 Apr; 6(10):7727-40. PubMed ID: 25762628 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10. Stone JG; Eeles RA; Sodha N; Murday V; Sheriden E; Houlston RS Cancer Lett; 1999 Dec; 147(1-2):181-5. PubMed ID: 10660104 [TBL] [Abstract][Full Text] [Related]